Events attended by Micrima
Micrima have attended the following events;
If you would like to find out more about some of our previous courses, workshops and conferences, please see the write-ups below taken from some of our courses held over recent months.
This year’s annual meeting for the British Society of Breast Radiologists was held in Bristol, home of Micrima. As always the event was really well attended by both the radiology community and commercial sponsors. The 3 day event was packed with insightful and educational presentations as well as allowing delegates to catch up with old friends and hear about the latest innovations. It was interesting to hear the thoughts on the differences in different units on detection rates and recall rates as well as hear about some of the thoughts and clinical studies coming up around what to do with ladies with dense breast tissue. The Micrima exhibition stand was busy with enquires and the team were happy to be able to update delegates regarding our clinical trials and exciting new developments.
Medical Imaging 2019
This year we again attended the Medical imaging Convention this time in Birmingham at the NEC. We were pleased to also have a Presentation in one of the Medical Imaging lecture theatres. This was given by David Gibbins one of the senior engineers in Micrima. He talked about radio-waves and their use in Breast Imaging. This was a great presentation with lots of questions afterwards from a very engaged audience.
This year’s ECR was attended by over 30,000 delegates. The theme of the meeting was ” the bigger picture” and we definitely believe Micrima has a big part to play in the Bigger picture in breast cancer detection. We were pleased to meet customers old and new this year to be able to update them on the new developments within this breast imaging system. We were also keen to show our new stand highlighting the MARIA® radio-wave technology. There was lots of debate again this year on AI and how breast screening is likely to change.
Micrima attended and helped sponsor this year’s annual meeting for the British Society of Breast Radiologists (BSBR). The event (held between the 4th and 6th of November in Gateshead) was very well attended and addressed current challenges for the breast imaging community as well as the developments that could shape the future.
Day one focused on technology and trial updates. Interesting talks from various clinicians around the UK involved in the latest trials providing information on the SMALL, NOSTRA and OPTIMAM projects. This was followed by interesting presentations on AI and its possible uses in breast radiology. The day was finished with a presentation on academic research in the USA.
Day two continued with presentations on some of the current controversies in breast radiology, more on the digital era and how this may influence breast radiology. The day closed with interesting talks regarding trials in Breast Imaging. The LIESL trial at the Royal Marsden using MARIA® was featured in this section.
The final day concentrated on the future direction of breast radiology, followed by 6 offered papers.
As well as exhibiting the MARIA® technology, Micrima were also represented in the poster exhibition with an overview of the LIESL trial providing initial observations from this important clinical study being run at the Royal Marsden Hospital in London.
The event which was once again hosted at the ACC in Liverpool was very well attended as always, and the organising committee had performed a fantastic job in getting great speakers and presenters delivering educational and thought-provoking lectures. With many delegates having earned their right to attend the meeting through the numerous posters that they had produced, there was also a strong drive to keep breast imaging evolving and the performance of clinical delivery improving. This year’s event saw an increased interest in the subject of breast density and the possible ways that the breast imaging community could utilise the increased understanding of this important risk factor to improve the services offered to those women who have dense breast tissue.
The Micrima exhibition stand at this year’s Symposium Mammographicum meeting has been busy with delegates keen to find out how our latest clinical trials are progressing. Whilst other delegates new to the technology were just intrigued by the fact it requires no radiation or breast compression.
The annual ECR congress was held in Vienna. With a record attendance of 28,474 total participants from around the globe. As usual there was a busy breast imaging programme as part of this meeting. There was lots of discussion around methods of detection finding more cancers but are these the right cancers? It was felt what is needed was a way to detect cancer that can go on to be a problem. There was also lots of talk about AI and machine learning at the congress in general. some concern over was the machine going to replace the radiologist but an overall feel it would enhance the job taking away some tasks but allowing radiologists to focus on other parts of the job.
This was a busy ECR for Micrima with the main congress and a side event on the 2nd of March to introduce radio-wave technology and MARIA® to a select group. Micrima also had poster at this year ECR looking at using MARIA® to measure tissue density. Another topic that was discussed in the Breast imaging sessions.
The BSBR meeting was held in Croke Park Dublin which was the first time the ASM has been held outside the U.K
The meeting covered a wide range of current issues and topics. These included new imaging techniques such as PET CT and discussion about current double vs single reading for mammography imaging in breast screening. This is a very relevant, widely debated topic addressing the workforce crisis in breast imaging that looms visibly in the future but seeking the answer to continue delivering the highest standards of care.
Current issues in breast cancer management were covered with a very interesting lecture given by Dr Penny Moyle discussing onco-plastic breast conserving surgery. The patient expectation of safe cancer treatment with a good aesthetic outcome is becoming a widely held expectation supported by a growing body of evidence that patients demonstrate a better psychological outcome with good cosmesis. The lecture covered information on the techniques involved in oncoplastic breast surgery and how these impact breast imaging including long term follow up.
A very interesting lecture on the final day discussed the impact of weight change between the age of 20 and breast screening age which produced some interesting conclusions. Weight gain is associated with higher absolute breast density and may confer a higher breast cancer risk.
The Oncoplastic and reconstructive breast surgery meeting was held at Nottingham University and was attended by delegates predominantly from the UK with some overseas. The meeting focussed on breast conserving surgery, evidence based outcomes, mastectomy =/- reconstruction, implants and radiotherapy and autologous flaps and adjuvant radiotherapy.
An interesting and slightly controversial lecture was delivered discussing DCIS, including the need for radiotherapy, the accepted clear margin size, the considerations for mastectomy and the consideration of endocrine and Herceptin treatment in young patients with high grade disease and casting calcifications. The discussion revolved around the considerations of the age of the patient, the grade of the disease and the tumour size.
An informative lecture was given about ALCL (Anaplastic Large Cell Lymphoma) which is seen in patients who have had breast implants placed. It was established that this is a very rare cancer but when diagnosed appears in implants that have a textured surface and is thought to involve an allergic cascade. Covered in the lecture was diagnosis, treatment with notable good prognosis. 28 cases have been diagnosed in the U.K with 409 cases diagnosed worldwide.
The EUSOBI congress was held in Berlin this year just 2 days before the Berlin marathon. Over 800 delegates attended mainly from Europe but also some from the rest of the world. The meeting covered topics such as challenges to face in future screening, News in MRI, increased risk of breast cancer and tumour and biology radiomics. There were also some interesting perspectives from Germany, USA and Canada on screening programmes and MRI. Our exhibition booth was busy on both days but especially after Micrima presented on Radio-wave imaging in dense and heterogeneously dense breast tissue on Friday morning.
The international Cambridge Conference on Breast Cancer Imaging, hosted by the Cambridge Breast unit took place at the west road concert hall in Cambridge. The meeting was attended by delegates and faculty from all over the globe. The focus this year was personalised imaging and there were lots of presentations and discussion on how to proceed in a changing world of imaging. MARIA® was well received both in the poster presentation and by delegates who thought it had a real part to play in personalised imaging.
The fourth annual Private Healthcare Summit took place on Tuesday, June 20th, 2017 at the QE II Centre in the heart of Westminster. Keith Pollard and Sue Saville opened the meeting which examined how the sector can develop the market for private healthcare through partnership, innovation, delivering value and world class care.There were excellent speakers discussing important topics today such as cyber security, the future shape of private healthcare, the future of PMI, enhancing the patient experience and new models new relationships. Micrima took this opportunity to showcase MARIA® to the private healthcare market, sharing the great opportunities they offered in today’s market where differentiation in services is so important.
Micrima was one of the key sponsors for this meeting. It was a gathering of all disciplines involved in the diagnosis, treatment and care of breast cancer patients. Delegates came from 14 different countries. They debated the key topics in breast cancer care at the moment. There were lots of opportunities for Micrima to mix with the delegates and faculty at networking sessions. In these sessions, we discussed how a new breast imaging technology like MARIA® could be of use. As it uses harmless radio waves instead of conventional ionising radiation and no compression. We also discussed the need for an imaging modality that was appropriate and effective for younger patients.
Micrima was proud to be the sole sponsor of the association of breast clinicians study day in Bristol. The meeting was well attended by breast clinicians from across the country. It covered topics key in breast care at the moment. Micrima had the opportunity to share the recent results from our multicentre trial with the group as part of the programme which was well received.
Christian Graff, PhD has emigrated to the UK to join the development team at Micrima Ltd to work with Artificial …
Hologic to act as Micrima’s distribution partner in Germany, Austria and Switzerland
Micrima Ltd is pleased to announce that it has …